Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Mottram

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Transplantation|August 5, 2000
Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient miceW R Han, Y Zhan, L J Murray-Segal, et al.
The Journal of Experimental Medicine|December 1, 1982
A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cellsD J Kemp, J M Adams, P L Mottram, et al.
Transplantation|April 1, 1990
A rabbit model for heterotopic cardiac transplantationS V Mitchell, P L Mottram, L J Purcell, et al.
Transplantation|March 1, 1993
Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in miceP L Mottram, G A Pietersz, M J Smyth, et al.
Immunology|March 1, 1996
Engineering of recombinant soluble CD46: an inhibitor of complement activationD Christiansen, J Milland, B R Thorley, et al.
Transplantation|October 6, 1997
Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in miceP L Mottram, W R Han, L J Murray-Segal, et al.
Transplantation|October 1, 1989
Immunosuppressive and cardiotoxic effects of cyclosporine in CBA miceP L Mottram, A Mirisklavas, A Mason, et al.
Transplantation Proceedings|February 1, 1987
Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allograftsA Mirisklavos, P L Mottram, J A Smith, et al.
Transplant Immunology|January 19, 2000
Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allograftsW R Han, L J Murray-Segal, A Gershenzon, et al.
Transplant Immunology|October 30, 2001
Blockade of the CD28 and CD40 pathways result in the acceptance of pig and rat islet xenografts but not rat cardiac grafts in miceA M Lehnert, P L Mottram, W Han, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Transplantation|August 5, 2000
Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient miceW R Han, Y Zhan, L J Murray-Segal, et al.
The Journal of Experimental Medicine|December 1, 1982
A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cellsD J Kemp, J M Adams, P L Mottram, et al.
Transplantation|April 1, 1990
A rabbit model for heterotopic cardiac transplantationS V Mitchell, P L Mottram, L J Purcell, et al.
Transplantation|March 1, 1993
Evidence that an anthracycline-anti-CD8 immunoconjugate, idarubicin-anti-Ly-2.1, prolongs heart allograft survival in miceP L Mottram, G A Pietersz, M J Smyth, et al.
Immunology|March 1, 1996
Engineering of recombinant soluble CD46: an inhibitor of complement activationD Christiansen, J Milland, B R Thorley, et al.
Transplantation|October 6, 1997
Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in miceP L Mottram, W R Han, L J Murray-Segal, et al.
Transplantation|October 1, 1989
Immunosuppressive and cardiotoxic effects of cyclosporine in CBA miceP L Mottram, A Mirisklavas, A Mason, et al.
Transplantation Proceedings|February 1, 1987
Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allograftsA Mirisklavos, P L Mottram, J A Smith, et al.
Transplant Immunology|January 19, 2000
Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allograftsW R Han, L J Murray-Segal, A Gershenzon, et al.
Transplant Immunology|October 30, 2001
Blockade of the CD28 and CD40 pathways result in the acceptance of pig and rat islet xenografts but not rat cardiac grafts in miceA M Lehnert, P L Mottram, W Han, et al.
Pageof 6